Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Nuclear Medicine Communications|May 27, 2003
Prediction of functional recovery after coronary bypass surgery using quantitative gated myocardial perfusion SPECTM Mabuchi, N Kubo, K Morita, et al.
Kaku Igaku. the Japanese Journal of Nuclear Medicine|December 10, 1999
[Synthesis of 18F-FDG with FDG MicroLab system: basic studies for clinical application]Y Kuge, E Tsukamoto, C Katoh, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 5, 2001
Comparison of (18)F-FDG, (131)I-Na, and (201)Tl in diagnosis of recurrent or metastatic thyroid carcinomaT Shiga, E Tsukamoto, K Nakada, et al.
Nuclear Medicine Communications|April 21, 2001
Thalamic asymmetry on interictal SPECT in patients with frontal lobe epilepsyA Takano, T Shiga, J Kobayashi, et al.
Kaku Igaku. the Japanese Journal of Nuclear Medicine|April 1, 1993
[Phase II clinical study of 99mTc-MAG3]K Ishii, A Ishibashi, E Tsukamoto, et al.
Nuclear Medicine Communications|April 30, 2003
Transient left ventricular dysfunction in ischaemic myocardium after stress: comparative study with exercise and pharmacological stress gated myocardial single photon emission computed tomographyY Iwado, H Furuyama, K Yoshinaga, et al.
Annals of Nuclear Medicine|March 1, 1991
Single photon emission computed tomography with Tc-99m-dimercaptosuccinic acid in patients with upper urinary tract infection and/or vesicoureteral refluxK Itoh, Y Asano, E Tsukamoto, et al.
Annals of Nuclear Medicine|February 14, 1998
Sequential change of BMIPP uptake with age in spontaneously hypertensive rat modelT Mochizuki, E Tsukamoto, T Ono, et al.
Nuclear Medicine Communications|May 25, 2002
Fluorodeoxyglucose uptake and glucose transporter expression in experimental inflammatory lesions and malignant tumours: effects of insulin and glucose loadingS Zhao, Y Kuge, E Tsukamoto, et al.
Kaku Igaku. the Japanese Journal of Nuclear Medicine|November 1, 1995
[Phase 3 multicenter clinical study of 111In-DTPA-D-octreotide (MP-1727) in patients with gastrointestinal hormone producing tumors]K Yamamoto, Y Ishii, M Furudate, et al.
Pageof 8